source
- China's new supply chain rules threaten Western pharma as Beijing tightens control over biotech importsChina has rapidly expanded its role in drug development, moving from less than 8% of global clinical trials in 2010 to overtaking the United States in trial volume by 2020, with more than 5,000 tri…
- French regulator fines Novo Nordisk and Eli Lilly for misleading weight loss adsFrench medicines regulator ANSM imposed fines on Novo Nordisk and Eli Lilly for advertising practices linked to their weight loss drugs. Novo Nordisk was fined about $2 million for ads promoting W…